Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Selby

Showing results (231-240 of 264) with videos related to

Pageof 27
Sort By:
British Journal of Cancer|July 2, 1999
Mutation testing in melanoma families: INK4A, CDK4 and INK4DJ A Newton Bishop, M Harland, D C Bennett, et al.
The American Journal of Drug and Alcohol Abuse|February 26, 2010
Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samplesH E Jones, S H Heil, K E O'Grady, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2005
Insecticidal anthranilic diamides: a new class of potent ryanodine receptor activatorsGeorge P Lahm, Thomas P Selby, John H Freudenberger, et al.
Bone|March 15, 2001
Effects of clodronate on vertebral fracture risk in osteoporosis: a 1-year interim analysisE McCloskey, P Selby, D de Takats, et al.
British Journal of Cancer|May 18, 2001
ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trialB W Hancock, W M Gregory, M H Cullen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepamD Cunningham, M Dicato, J Verweij, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2013
Discovery of cyantraniliprole, a potent and selective anthranilic diamide ryanodine receptor activator with cross-spectrum insecticidal activityThomas P Selby, George P Lahm, Thomas M Stevenson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2M H Vitaterna, C P Selby, T Todo, et al.
Human Molecular Genetics|November 5, 1997
Germline mutations of the CDKN2 gene in UK melanoma familiesM Harland, R Meloni, N Gruis, et al.
Gene Therapy|October 26, 2016
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapyE Ilett, T Kottke, J Thompson, et al.
Pageof 27

Showing results (231-240 of 264) with videos related to

Sort By:
Pageof 27
British Journal of Cancer|July 2, 1999
Mutation testing in melanoma families: INK4A, CDK4 and INK4DJ A Newton Bishop, M Harland, D C Bennett, et al.
The American Journal of Drug and Alcohol Abuse|February 26, 2010
Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samplesH E Jones, S H Heil, K E O'Grady, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2005
Insecticidal anthranilic diamides: a new class of potent ryanodine receptor activatorsGeorge P Lahm, Thomas P Selby, John H Freudenberger, et al.
Bone|March 15, 2001
Effects of clodronate on vertebral fracture risk in osteoporosis: a 1-year interim analysisE McCloskey, P Selby, D de Takats, et al.
British Journal of Cancer|May 18, 2001
ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trialB W Hancock, W M Gregory, M H Cullen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepamD Cunningham, M Dicato, J Verweij, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2013
Discovery of cyantraniliprole, a potent and selective anthranilic diamide ryanodine receptor activator with cross-spectrum insecticidal activityThomas P Selby, George P Lahm, Thomas M Stevenson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2M H Vitaterna, C P Selby, T Todo, et al.
Human Molecular Genetics|November 5, 1997
Germline mutations of the CDKN2 gene in UK melanoma familiesM Harland, R Meloni, N Gruis, et al.
Gene Therapy|October 26, 2016
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapyE Ilett, T Kottke, J Thompson, et al.
Pageof 27